本文へ移動
cccskills
無料GitHub で公開

pediatric-obesity-surgical-screener

Screen a child aged 13+ with obesity for eligibility for bariatric surgery (laparoscopic sleeve gastrectomy or Roux-en-Y gastric bypass) using the CMAJ 2025 guideline. Trigger when a clinician asks whether a child qualifies for weight loss surgery, bariatric surgery in adolescents, sleeve gastrectomy in a teenager, or when to refer for surgical management of pediatric obesity.

インストール方法を見る

含まれるファイル(1)

  • SKILL.md6.4 KB

SKILL.md(原文)

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Pediatric Obesity: Surgical Eligibility Screener

Step-by-step checklist to determine if a child with obesity is a candidate for bariatric surgery and to guide the pre-referral workup and shared decision-making conversation.

Based on CMAJ 2025 Clinical Practice Guideline (Ball et al., doi: 10.1503/cmaj.241456).


Step 1 — Basic Eligibility Criteria

CriterionThreshold
Age≥ 13 years (evidence base is exclusively ≥13)
Obesity severitySevere obesity confirmed by comprehensive health assessment
Multidisciplinary teamAssessment by a specialized multidisciplinary team is required
SettingSurgical centre with paediatric bariatric program

⚠️ Surgery does not require prior failure of pharmacotherapy. Offer based on clinical severity, family preference, comorbidities, and centre availability — not as a last resort after exhausting all other options.

⚠️ Centres performing bariatric surgery in adolescents are limited in Canada. Check availability in your region before raising expectations with the family.


Step 2 — Comprehensive Health Assessment (4Ms)

Assess all four domains before referral:

Metabolic

  • Insulin resistance / type 2 diabetes
  • Dyslipidaemia (↑TG, ↓HDL-C, ↑LDL-C)
  • Hypertension
  • Non-alcoholic fatty liver disease (↑ALT)
  • Obstructive sleep apnea (consider sleep study)

Mechanical

  • Musculoskeletal pain (knees, back, hips)
  • Mobility limitations
  • Exercise tolerance

Mental Health (critical — do not skip)

  • Depression and anxiety screening
  • Eating disorder screen (binge eating disorder, atypical anorexia, purging) — psychiatric clearance required before surgery
  • Body image and self-esteem
  • Bullying history
  • Caregiver mental health

Social Milieu

  • Family support and stability
  • Food security
  • Housing and neighbourhood safety
  • Caregiver ability to support post-operative recovery and behavioural changes
  • School and peer environment

Step 3 — Pre-Operative Multidisciplinary Assessment

The following specialists should be involved (where available):

SpecialistRole
Paediatric surgeon / bariatric surgeonSurgical planning, risk stratification
Paediatrician / obesity medicine physicianOverall obesity management
DietitianPre- and post-operative nutritional counselling
Psychologist / psychiatristMental health clearance, body image, eating disorder screen
Social workerSocial support, family stability, access to follow-up
Kinesiologist (where available)Physical activity readiness

Step 4 — Surgical Options

Both options are conditional recommendations, low to moderate certainty. Both require concurrent behavioural and psychological interventions.

Laparoscopic Sleeve Gastrectomy (LSG)

  • HRQoL: very large effect (critically important outcome)
  • Weight and BMI: substantial reduction (very important outcome)
  • Anxiety and depression: no data available
  • Serious AEs: higher incidence than non-surgical comparators (important — discuss explicitly)
  • Mild-moderate AEs: higher incidence (nausea, vomiting, reflux)

Roux-en-Y Gastric Bypass (RYGB)

  • HRQoL: large effect
  • Anxiety and depression: small effect (beneficial)
  • Weight and BMI: substantial reduction
  • Serious AEs: higher incidence than non-surgical comparators (important — discuss explicitly)
  • Mild-moderate AEs: higher incidence
  • Higher technical complexity; nutritional monitoring more intensive

Which to choose? The guideline does not mandate one over the other — choice depends on surgical expertise, anatomical factors, patient preference, and centre experience.


Step 5 — Shared Decision-Making Conversation

Before referral or consent, cover explicitly:

  1. Expected benefits: Large improvements in HRQoL and substantial weight/BMI reduction; cardiometabolic improvements likely
  2. Serious AE risk: Higher than non-surgical management — must be disclosed; includes complications requiring hospitalisation
  3. Lifestyle commitment: Surgery requires lifelong dietary changes, vitamin supplementation, and behavioural support
  4. No guarantee of sustained weight loss without maintained behavioural changes
  5. Alternatives: Confirm family has considered pharmacotherapy and intensified behavioural intervention
  6. Family/caregiver support: Post-operative period requires strong family engagement

Involve both the child and caregivers. The child's own voice matters — especially for adolescents.


Step 6 — Post-Operative Monitoring

Minimum monitoring plan after surgery:

TimepointWhat to monitor
1–3 monthsWound healing, GI tolerance, nutritional status, weight
6 monthsBMIz, cardiometabolic markers, mental health screen, eating behaviours
12 monthsHRQoL, nutritional deficiencies (iron, B12, vitamin D, calcium), weight trajectory
OngoingAnnual metabolic screen; eating disorder vigilance; transition to adult care planning

Clinical Guardrails

  • Eating disorder is a relative contraindication — psychiatric clearance is mandatory. Active binge eating disorder requires treatment before surgery.
  • Age < 13: Do not refer — evidence was derived exclusively from ≥13-year-olds.
  • Technology-only interventions are insufficient as a pre-operative behavioural program — ensure a proper multicomponent program is in place.
  • Ongoing behavioural/psychological support post-operatively is required — surgery alone is not adequate management.
  • Transition planning: Begin discussing adult care transition from the time of surgery, especially for 16+ year-olds.
  • Lipase inhibitors: Not a surgical alternative — do not substitute.

Source

CMAJ 2025 Clinical Practice Guideline: Managing obesity in children. Ball GDC et al. CMAJ 2025 April 14; 197:E372–89. doi: 10.1503/cmaj.241456 Updated version: June 3, 2025.

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

同じリポジトリのスキル

概要と使いどころ

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する